Search results for "cancer treatment"

showing 10 items of 133 documents

Gold nanoparticle interactions with endothelial cells cultured under physiological conditions

2017

PEGylated gold nanoparticles (AuNPs) have an extended circulation time after intravenous injection in vivo and exhibit favorable properties for biosensing, diagnostic imaging, and cancer treatment. No impact of PEGylated AuNPs on the barrier forming properties of endothelial cells (ECs) has been reported, but recent studies demonstrated that unexpected effects on erythrocytes are observed. Almost all studies to date have been with static-cultured ECs. Herein, ECs maintained under physiological cyclic stretch and flow conditions and used to generate a blood-brain barrier model were exposed to 20 nm PEGylated AuNPs. An evaluation of toxic effects, cell stress, the release profile of pro-infla…

SwineBiomedical EngineeringNanoparticleNanotechnology02 engineering and technology010402 general chemistryBlood–brain barrier01 natural sciencesPolyethylene GlycolsIn vivoHuman Umbilical Vein Endothelial CellsMedicineAnimalsHumansGeneral Materials ScienceParticle SizeCells Culturedbusiness.industryEndothelial Cells021001 nanoscience & nanotechnologyQPR10104 chemical sciencesCancer treatmentCell stressmedicine.anatomical_structureColloidal goldBlood-Brain BarrierBiophysicsNanoparticlesCirculation timeGold0210 nano-technologybusinessBlood stream
researchProduct

Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin

2021

Nanoparticles (NPs) have emerged as a potential tool to improve cancer treatment. Among the proposed uses in imaging and therapy, their use as a drug delivery scaffold has been extensively highlighted. However, there are still some controversial points which need a deeper understanding before clinical application can occur. Here the use of gold nanoparticles (AuNPs) to detoxify the antitumoral agent cisplatin, linked to a nanoparticle via a pH-sensitive coordination bond for endosomal release, is presented. The NP conjugate design has important effects on pharmacokinetics, conjugate evolution and biodistribution and results in an absence of observed toxicity. Besides, AuNPs present unique o…

Time FactorsCancer TreatmentMetal Nanoparticleslcsh:MedicinePharmacologyMiceNanotechnologyTissue Distributionlcsh:Sciencemedia_commonDrug DistributionDrug CarriersMultidisciplinaryChemistryDNA NeoplasmOrgan SizeHydrogen-Ion ConcentrationEndocytosisOncologyColloidal goldDrug deliveryInactivation MetabolicMedicinemedicine.drugResearch ArticleBiotechnologyDrugBiodistributionDrugs and Devicesmedia_common.quotation_subjectMaterials ScienceAntineoplastic AgentsMaterial by AttributePharmacokineticsCell Line TumormedicineAnimalsHumansPharmacokineticsBiologyNanomaterialsCisplatinUnited States Food and Drug Administrationlcsh:RChemotherapy and Drug TreatmentUnited StatesBionanotechnologylcsh:QGoldNanocarriersCisplatinConjugate
researchProduct

Use of trastuzumab for breast cancer: the impact of age.

2014

Indication for the use of trastuzumab was given in Italy in 2000 for the treatment of HER-2 metastatic breast cancer and in 2006 for early stage breast cancer. Information on trastuzumab use and on its possible variation with age in Italy is however limited. Using health care administrative databases, we evaluated the prevalence of the use of trastuzumab, and the probability for administration since the first hospitalization for breast cancer in various age groups, in two series of Italian women diagnosed with breast cancer in the Lombardy region (2004-2009) and in the Palermo district. The rate between trastuzumb users and patients with a hospitalization for breast cancer increased from 2.…

Trastuzumab early breast cancer metastatic breast cancer breast cancer treatment elderly.Settore MED/42 - Igiene Generale E Applicata
researchProduct

Publicidad y cáncer en la prensa escrita (1903-1912)

2020

El cáncer es una de las enfermedades más graves de nuestro tiempo debido a su elevada prevalencia, morbilidad y mortalidad, lo que la ha convertido en contenido habitual de la información periodística a lo largo de la historia. En este artículo se pretende analizar cómo fueron los anuncios publicitarios relativos a los productos, establecimientos y servicios que se ofertaban a principios del siglo XX en España, en relación con la enfermedad del cáncer, así como realizar una aproximación a la realidad social, cultural y educativa en el periodo de tiempo estudiado. A partir de la hemeroteca digital de los periódicos ABC y La Vanguardia, se seleccionaron todos los anuncios publicitarios que ap…

TreatmentHigh prevalenceAdvertisingHealingPolitical scienceTratamientoGeneral MedicinePublicidadCáncerHumanitiesCuraciónCancer treatmentCancer
researchProduct

To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic

2020

PLOS ONE 15(9), e0239027 (2020). doi:10.1371/journal.pone.0239027

Viral DiseasesUrologistsMedizinCancer TreatmentGermanMedical ConditionsRobotic Surgical ProceduresGermanySurveys and QuestionnairesPandemicMedicine and Health SciencesResponse rate (survey)MultidisciplinaryProstate CancerQRProstate DiseasesHospitalizationInfectious DiseasesSurgical OncologyOncologylanguageMedicineCoronavirus InfectionsResearch ArticleUrologic DiseasesClinical Oncologymedicine.medical_specialtyScienceHealth PersonnelUrologyPneumonia ViralMEDLINESurgical and Invasive Medical ProceduresRobotic Assisted SurgeryBetacoronavirusmedicineHumansPenile cancerRobotic surgeryBetacoronavirus; COVID-19; Coronavirus Infections; Germany; Health Personnel; Hospitalization; Humans; Internet; Pandemics; Personal Protective Equipment; Pneumonia Viral; Robotic Surgical Procedures; SARS-CoV-2; Surveys and Questionnaires; Urologic Diseases; UrologistsPandemicsPersonal Protective EquipmentPersonal protective equipmentInternetUrologic InfectionsSARS-CoV-2COVID-19 ; Urology ; Surgical and invasive medical procedures ; Urologic infections ; Surgical oncology ; Robotic assisted surgery ; Cancer treatment ; Prostate cancerGenitourinary Infectionsbusiness.industryGeneral surgeryCOVID-19Cancers and NeoplasmsRobotic Surgical ProceduresCovid 19medicine.diseaselanguage.human_languageGenitourinary Tract TumorsClinical MedicinebusinessPLOS ONE
researchProduct

Hsp60, a Novel Target for Antitumor Therapy: Structure-Function Features and Prospective Drugs Design

2013

Heat shock protein 60 kDa (Hsp60) is a chaperone classically believed to be involved in assisting the correct folding of other mitochondrial proteins. Hsp60 also plays a role in cytoprotection against cell stressors, displaying for example, antiapoptotic potential. Despite the plethora of studies devoted to the mechanism of Hsp60's function, especially in prokaryotes, fundamental issues still remain unexplored, including the definition of its role in cancer. Key questions still unanswered pertain to the differences in structure-function features that might exist between the well-studied prokaryotic GroEL and the largely unexplored eukaryotic Hsp60 proteins. In this article we discuss these …

animal structuresBinding pocketCellAntineoplastic Agentschemical and pharmacologic phenomenaComputational biologyBiologyBioinformaticsFunctional domaincomplex mixturesChaperoninStructure-Activity RelationshipNeoplasmsHeat shock proteinDrug DiscoverymedicineHumansPharmacologyCompound dockingSettore BIO/16 - Anatomia UmanaCell growthfungiSettore CHIM/06 - Chimica OrganicaChaperonin 60Hsp60Settore CHIM/08 - Chimica FarmaceuticaCytoprotectionGroELmedicine.anatomical_structureSettore CHIM/03 - Chimica Generale E InorganicaCancer treatmentDrug DesignChaperone (protein)biology.proteinHSP60Protein foldingEpolactaeneCurrent Pharmaceutical Design
researchProduct

Plexin-B1 activates NF-κB and IL-8 to promote a pro-angiogenic response in endothelial cells.

2011

Background The semaphorins and their receptors, the plexins, are proteins related to c-Met and the scatter factors that have been implicated in an expanding signal transduction network involving co-receptors, RhoA and Ras activation and deactivation, and phosphorylation events. Our previous work has demonstrated that Semaphorin 4D (Sema4D) acts through its receptor, Plexin-B1, on endothelial cells to promote angiogenesis in a RhoA and Akt-dependent manner. Since NF-κB has been linked to promotion of angiogenesis and can be activated by Akt in some contexts, we wanted to examine NF-κB in Sema4D treated cells to determine if there was biological significance for the pro-angiogenic phenotype o…

animal structuresRHOAProto-Oncogene Proteins c-aktAngiogenesisSignaling in cellular processesG-protein signalingCancer TreatmentSEMA4Dlcsh:MedicineSignal transductionBiology03 medical and health sciencesMolecular cell biology0302 clinical medicineSemaphorinSettore BIO/10 - BiochimicaAkt Signaling CascadeMembrane Receptor SignalingInterleukin 8lcsh:ScienceBiologyProtein kinase BGTPase signalingRas signaling030304 developmental biology0303 health sciencesMultidisciplinaryMechanisms of Signal Transductionlcsh:RSignaling Cascades3. Good healthCell biologyPlexin B1RNA interferencepro-angiogenicendothelial cellsOncology030220 oncology & carcinogenesisembryonic structuresCancer researchbiology.proteinMedicinelcsh:QAntiangiogenesis TherapyAntiapoptotic signalingSignal transductionResearch ArticlePLoS ONE
researchProduct

Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment

2014

Cancer is one of the most urgent health issues of today. According to WHO, the number of cancer cases is expected to increase by 75% in the next two decades (1). Despite some remarkable achievements in the fields of cancer prevention and early detection, the goal of developing effective anti-cancer therapies still remains unmet. Tumor recurrence due to treatment resistance is the most common cause of death from cancer. Delineating cellular and molecular mechanisms underlying tumor recurrence is of prime importance for the ability to improve the efficacy of existing therapies and develop new strategies to cancer treatment.

cancer stem cellsCancer Researchmedicine.medical_specialtytumor clones selectionEarly detectionintratumor heterogeneityBioinformaticslcsh:RC254-282Intratumor heterogeneityCancer stem cellmedicinecancerTreatment resistanceIntensive care medicineCancer preventionbusiness.industryintratumor spatiotemporal patternsCancerOpinion Articlelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasetumor recurrenceCancer treatmentTumor recurrenceOncologybusinessanti-cancer therapyFrontiers in Oncology
researchProduct

Komplementāras terapijas lietošana pacientiem, kas saņem pretvēža ārstēšanu - biežums, anamnēzes dokumentācija, un iespējamā mijiedarbība ar terapiju

2015

Ievads Pētījuma mērķis bija komplementārās un alternatīvās medicīnas (KAM) pielietošanas analīze plaušu vēža pacientu vidū, kas saņem standarta pretvēža terapiju; izvērtēt, kāds KAM veids ir vispopulārākais, kāda ir pacientu motivācija to izmantot, kā arī novērtēt ar KAM saistītās priekšrocības, toksicitātes un riskus. Metodes Pētījumā tika iekļauti izplatīta sīkšūnu un ne-sīkšūnu plaušu vēža pacienti, kas saņem paliatīvu ķīmijterapiju un/vai staru terapiju Paula Stradiņa Klīniskās Universitātes Slimnīcas Onkoloģijas klīnikā (Rīga). Dalībniekiem tika piedāvāta aprakstoša anketa latviešu un krievu valodās. Atbilžu precizēšanai tika izmantotas pus-strukturētas intervijas. Dati par toksicitāti…

conventional anticancer treatmentalternative medicinecomplementary medicineLung cancerMedicīna
researchProduct

radioterapia para el tratamiento del cáncer en la publicidad de principios del s. XX

2021

El descubrimiento de los rayos X y del radium generó gran curiosidad entre los científicos. Ambos elementos representaban la cura milagrosa que podría tratar una amplia gama de enfermedades mortales, como el cáncer, pudiendo llegar a colmar las expectativas de la población. El objetivo de dicho artículo es analizar las inserciones publicitarias relativas al radium y los rayos X aplicadas para el tratamiento del cáncer, en la prensa española a comienzos del siglo XX (1903-1912), en los periódicos ABC y La Vanguardia. Para ello, a partir de la hemeroteca digital de ambos medios se seleccionaron todas y cada una de las veces que se pudo identificar el término “cáncer” en los anuncios publicita…

education.field_of_studyHistoryMiraclemedia_common.quotation_subjectPopulationMedia studiesCuriosityGeneral MedicineeducationCancer treatmentmedia_commonNewspaperVivat Academia. Revista de Comunicación
researchProduct